Tickling PARPs into serine action

[1]  I. Ahel,et al.  HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation , 2020, Nature.

[2]  I. Matic,et al.  Serine is the major residue for ADP-ribosylation upon DNA damage , 2018, eLife.

[3]  Arnab Ray Chaudhuri,et al.  The multifaceted roles of PARP1 in DNA repair and chromatin remodelling , 2017, Nature Reviews Molecular Cell Biology.

[4]  M. Robson,et al.  Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation , 2017, The New England journal of medicine.

[5]  I. Matic,et al.  Serine ADP-Ribosylation Depends on HPF1 , 2017, Molecular cell.

[6]  Ziying Liu,et al.  PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. , 2017, Genes & development.

[7]  M. L. Nielsen,et al.  Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue , 2016, Nature Communications.

[8]  I. Matic,et al.  Serine is a new target residue for endogenous ADP-ribosylation on histones , 2016, Nature chemical biology.

[9]  I. Ahel,et al.  HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity , 2016, Molecular cell.

[10]  Jamin D Steffen,et al.  PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain. , 2015, Molecular cell.

[11]  M. O’Connor,et al.  Targeting the DNA Damage Response in Cancer. , 2015, Molecular cell.

[12]  I. Ahel,et al.  Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation. , 2015, Molecular cell.

[13]  Anthony K. L. Leung,et al.  Phosphoproteomic Approach to Characterize Protein Mono- and Poly(ADP-ribosyl)ation Sites from Cells , 2014, Journal of proteome research.

[14]  David R Goodlett,et al.  Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography-tandem mass spectrometry. , 2013, Journal of proteome research.

[15]  V. Schreiber,et al.  The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. , 2012, Biochemical pharmacology.

[16]  W. Kraus,et al.  New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs , 2012, Nature Reviews Molecular Cell Biology.

[17]  J. Pascal,et al.  Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1 , 2012, Science.

[18]  D. Matei,et al.  Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. , 2012, The New England journal of medicine.

[19]  A. Caflisch,et al.  PARP1 ADP-ribosylates lysine residues of the core histone tails , 2010, Nucleic acids research.

[20]  Bernhard Lüscher,et al.  Toward a unified nomenclature for mammalian ADP-ribosyltransferases. , 2010, Trends in biochemical sciences.

[21]  P. Chambon,et al.  Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. , 1963, Biochemical and biophysical research communications.